Sam Gandy, MD, PhD, director of the Center for Cognitive Health at the Icahn School of Medicine at Mount Sinai, discussed his presentation on detecting toxic amyloid-β oligomers and their role in AD pathology at AAIC 2025.
Sam Gandy, MD, PhD
Advertisement
Director of the Center for Cognitive Health at the Icahn School of Medicine at Mount Sinai.
Articles by Sam Gandy, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
How Multiple Sclerosis Affects Men
2
ECTRIMS Congress 2025: Top Expert Interviews and Key Takeaways
3
NeurologyLive® Brain Games: October 12, 2025
4
The Future of Disease-Modifying Therapy in Epilepsy
5
